Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
INO80E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYO1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MRPL53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AGXT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPP25L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARVB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPATCH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEXA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2B4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM50A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUEDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on